Rep. Gilbert Ray Cisneros, Jr. Buys Stryker Corporation (NYSE:SYK) Shares

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Stryker Corporation (NYSE:SYK). In a filing disclosed on November 18th, the Representative disclosed that they had bought between $1,001 and $15,000 in Stryker stock on October 17th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of CommVault Systems (NASDAQ:CVLT) on 11/3/2025.
  • Sold $1,001 – $15,000 in shares of The Descartes Systems Group (NASDAQ:DSGX) on 11/3/2025.
  • Purchased $1,001 – $15,000 in shares of Cohen & Steers (NYSE:CNS) on 10/30/2025.
  • Purchased $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 10/30/2025.
  • Sold $1,001 – $15,000 in shares of UFP Industries (NASDAQ:UFPI) on 10/30/2025.
  • Purchased $1,001 – $15,000 in shares of Enerpac Tool Group (NYSE:EPAC) on 10/30/2025.
  • Sold $1,001 – $15,000 in shares of Sterling Infrastructure (NASDAQ:STRL) on 10/30/2025.
  • Purchased $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 10/21/2025.
  • Purchased $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 10/21/2025.
  • Purchased $1,001 – $15,000 in shares of Iberdrola (OTCMKTS:IBDSF) on 10/21/2025.

Stryker Stock Performance

Shares of NYSE:SYK traded up $3.21 on Monday, hitting $371.48. 262,034 shares of the company were exchanged, compared to its average volume of 1,443,089. The company’s 50 day moving average price is $369.38 and its two-hundred day moving average price is $380.68. The firm has a market capitalization of $142.06 billion, a price-to-earnings ratio of 49.19, a PEG ratio of 2.66 and a beta of 0.94. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19.

Stryker (NYSE:SYKGet Free Report) last released its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. During the same period last year, the business earned $2.87 earnings per share. The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $448.00 target price on shares of Stryker in a research report on Friday, November 14th. Rothschild Redb raised Stryker to a “hold” rating in a report on Thursday, September 18th. UBS Group set a $408.00 price target on shares of Stryker in a report on Monday, October 13th. Royal Bank Of Canada reissued an “outperform” rating and issued a $435.00 price objective on shares of Stryker in a research note on Friday, November 14th. Finally, Rothschild & Co Redburn assumed coverage on Stryker in a report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price objective on the stock. Thirteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $434.37.

Check Out Our Latest Report on SYK

Institutional Investors Weigh In On Stryker

Several large investors have recently made changes to their positions in the stock. United Services Automobile Association bought a new position in shares of Stryker in the 1st quarter valued at about $2,857,000. AXQ Capital LP acquired a new position in shares of Stryker in the second quarter valued at approximately $567,000. Hendley & Co. Inc. increased its position in Stryker by 60.3% during the 2nd quarter. Hendley & Co. Inc. now owns 14,018 shares of the medical technology company’s stock worth $5,546,000 after buying an additional 5,274 shares during the period. Two Point Capital Management Inc. acquired a new stake in Stryker in the 2nd quarter worth about $7,281,000. Finally, ABN AMRO Bank N.V. acquired a new stake in shares of Stryker in the second quarter valued at approximately $191,047,000. Institutional investors own 77.09% of the company’s stock.

Insider Activity

In related news, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the transaction, the chief financial officer directly owned 6,694 shares of the company’s stock, valued at $2,449,200.72. This trade represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO William E. Berry, Jr. sold 1,953 shares of Stryker stock in a transaction on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the completion of the transaction, the chief accounting officer owned 2,833 shares in the company, valued at approximately $1,035,433.17. The trade was a 40.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 522,118 shares of company stock worth $185,381,932. 5.90% of the stock is currently owned by corporate insiders.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Stryker Company Profile

(Get Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Recommended Stories

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.